SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry

scientific article published on 2 December 2015

SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12866-015-0605-3
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s12866-015-0605-3
P932PMC publication ID4667461
P698PubMed publication ID26630969
P5875ResearchGate publication ID285618909

P50authorHan-Dong SunQ89167622
P2093author name stringRu Bai
Hong-Bin Zhang
Yan-Li Li
Yong-Tang Zheng
Wei-Lie Xiao
Xing-Jie Zhang
Li-Xin Liu
Jian-Xin Pu
Jing-Ping Liu
P2860cites workImproved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimensQ24534391
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infectionQ24544232
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factorQ24547409
Active nuclear import of human immunodeficiency virus type 1 preintegration complexesQ24564507
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cellsQ24564509
The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytesQ24564711
The cell cycle independence of HIV infections is not determined by known karyophilic viral elementsQ24816846
CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 ReplicationQ27672646
Structural and Functional Analysis of the C-Terminal Domain of Nup358/RanBP2Q27676012
Discovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid ComplexesQ27678859
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cellsQ28249434
HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulatorQ28307391
Fates of retroviral core components during unrestricted and TRIM5-restricted infectionQ28487732
DB-02, a C-6-cyclohexylmethyl substituted pyrimidinone HIV-1 reverse transcriptase inhibitor with nanomolar activity, displays an improved sensitivity against K103N or Y181C than S-DABOsQ28535401
Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger proteinQ28576921
The HIV-1 reverse transcription (RT) process as target for RT inhibitorsQ28646665
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infectionQ28646834
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeysQ29547689
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitorQ29547710
Recruitment and dynamics of proteasome association with rhTRIM5α cytoplasmic complexes during HIV-1 infectionQ30543944
Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integrationQ31103609
Evidence for direct involvement of the capsid protein in HIV infection of nondividing cellsQ33304219
Flexible use of nuclear import pathways by HIV-1.Q33739260
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.Q33822095
Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.Q33851147
Structural biology of HIV.Q34068223
MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1Q34091405
Capsid is a dominant determinant of retrovirus infectivity in nondividing cellsQ34152408
Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challengesQ34348561
Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilizationQ39641782
Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cellsQ39822140
Sifuvirtide, a potent HIV fusion inhibitor peptide.Q39872319
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years laterQ40005181
The central DNA flap of the human immunodeficiency virus type 1 is important for viral replicationQ40233853
Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear importQ40408087
A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassemblyQ42126893
Enabled clinical use of an HIV-1 attachment inhibitor through drug deliveryQ42224900
The interferon-inducible MxB protein inhibits HIV-1 infection.Q42267969
HIV-1 infection requires a functional integrase NLS.Q44134677
Inhibition of HIV-1 nuclear import via schiff base formation with arylene bis(methylketone) compoundsQ44173878
Nuclear import of HIV-1 integrase is inhibited in vitro by styrylquinoline derivativesQ44973296
A nucleoprotein complex mediates the integration of retroviral DNA.Q46128219
A synthetic peptide bearing the HIV-1 integrase 161-173 amino acid residues mediates active nuclear import and binding to importin alpha: characterization of a functional nuclear localization signalQ47905706
Characterization of HIV replication complexes early after cell-to-cell infectionQ71602121
HIV-1 genome nuclear import is mediated by a central DNA flapQ73726795
Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complexQ73910247
Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycleQ34545869
Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzymeQ34674575
BI-2 destabilizes HIV-1 cores during infection and Prevents Binding of CPSF6 to the HIV-1 CapsidQ34738657
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteinsQ35101356
The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid.Q35140243
Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virusQ35140364
Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of actionQ35185934
Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signalQ35575399
The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsidQ35784739
HIV-1 antiretroviral drug therapyQ35853012
High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.Q35859304
Characterization of HIV-1 vpr nuclear import: analysis of signals and pathwaysQ36255858
Intracellular trafficking of retroviral vectors: obstacles and advancesQ36314656
Retroviral infection of non-dividing cells: old and new perspectivesQ36346812
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17Q36437723
Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alphaQ36446606
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.Q36684088
Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors".Q36949351
The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6.Q36964335
A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virusQ37002260
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cellsQ37186249
Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vectorQ37251114
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypesQ37251604
Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication.Q37386004
Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.Q37564101
The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifsQ37596510
Antiretroviral therapy and management of HIV infectionQ37770721
Multiple roles of the capsid protein in the early steps of HIV-1 infection.Q38049930
Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexesQ38150610
Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1Q38288599
Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected CellsQ38903364
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particlesQ39580545
A rapid in vitro polyomavirus DNA replication assayQ39631857
P304page(s)274
P577publication date2015-12-02
P1433published inBMC MicrobiologyQ15759430
P1476titleSJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry
P478volume15

Reverse relations

cites work (P2860)
Q46824083A Molecular Basis for the Inhibition of Transient Receptor Potential Vanilloid Type 1 by Gomisin A.
Q40051104Anti-HIV Activities and Mechanism of 12-O-Tricosanoylphorbol-20-acetate, a Novel Phorbol Ester from Ostodes katharinae.
Q50129893SJP-L-5 inhibits HIV-1 polypurine tract primed plus-strand DNA elongation, indicating viral DNA synthesis initiation at multiple sites under drug pressure.

Search more.